Ashford Capital Management’s Health Catalyst HCAT Stock Holding History

Ashford Capital Management’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-828,822	Closed	-$12M	–	93
2022 Q2	$12M	Buy	828,822 +355,470	+75%	+$6.06M	1.71%	24
2022 Q1	$12.4M	Sell	473,352 -25,830	-5%	-$733K	1.33%	30
2021 Q4	$19.8M	Sell	499,182 -21,230	-4%	-$968K	1.97%	23
2021 Q3	$26M	Buy	520,412 +12,070	+2%	+$658K	2.36%	13
2021 Q2	$28.2M	Sell	508,342 -600	-0.1%	-$32K	2.55%	13
2021 Q1	$23.8M	Buy	508,942 +43,320	+9%	+$2.1M	2.22%	17
2020 Q4	$20.3M	Buy	465,622 +123,122	+36%	+$4.54M	1.96%	23
2020 Q3	$12.5M	Buy	+342,500	New	+$11.6M	1.49%	30

Other funds holding HCAT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Ashford Capital Management's HCAT Position: Q3 2022 in Review

Ashford Capital Management sold out of Health Catalyst (HCAT) in Q3 2022, closing a stake of 828,822 shares — an estimated $12M sold.

Ashford Capital Management first reported a position in HCAT in Q3 2020 and held it in 8 quarters. The position peaked at $28.2M in Q2 2021. 171 funds tracked by Wall St. Rank hold HCAT as of Q3 2022.

Ashford Capital Management reported no remaining Health Catalyst position as of Q3 2022 after selling out during the quarter.
Ashford Capital Management sold 828,822 Health Catalyst shares in Q3 2022, an estimated $12M.
Ashford Capital Management first reported a position in Health Catalyst in Q3 2020 and held it in 8 quarters.
Ashford Capital Management's Health Catalyst position peaked at $28.2M in Q2 2021.
171 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2022.

Based on Ashford Capital Management's 13F filing for Q3 2022, filed 16 Nov 2022.